| Sep 22, 2012
| 11:52 AM
Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah.
That's because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2...
| Sep 25, 2012
| 3:12 PM
The American Civil Liberties Union has asked for a second time that the Supreme Court invalidate Myriad Genetics Inc.'s patents on two genes associated with hereditary breast and ovarian cancers, the latest salvo in a case with broad consequences for...
| Jun 27, 2013
| 8:10 AM
Nina, a resident of East Baltimore, celebrated her 41st birthday last Sunday. Surrounded by family and friends, she struggled for breath to extinguish the candles on her cake. Two years ago Nina was diagnosed with breast cancer. Genetic testing and...
| Jun 13, 2013
| 6:31 PM
Researchers hailed the Supreme Court ruling Wednesday that bans the patenting of human DNA, saying it would expand access to genetic testing for disease at lower cost to patients.
In a unanimous decision, the justices said Myriad Genetics did not have...
| Apr 28, 2013
| 5:00 AM
The greatest dangers to liberty lurk in the insidious encroachment by men of zeal, well meaning but without understanding. — Louis D. Brandeis
Just a few words and little thought separate yet another stronghold of the American economy from ruin....
| Oct 3, 2013
| 3:09 PM
What’s even more repulsive than the idea of using DNA tests to help people create a designer babies? Getting a patent for the idea.
23andMe, the pioneering direct-to-consumer genetic testing company, was awarded such a patent in September. U.S....
| Sep 30, 2013
| 6:30 AM
About Discovery Communications Inc.
What does the company do? Media and entertainment company
2010 Financial report:
Total revenues: $3.77 billion
Net income: $653 million
Q. Please advise me on my shares of Discovery...
| Sep 8, 2013
| 2:45 PM
Last week: Dolphins, your wins mean a lot more than you may think. A recent article by Pierre Chandon in Forbes Magazine brought to light how much we need our sports teams to win ... for our health. The article cites a study by Cornil and Chandon that...
| Jun 13, 2013
| 2:54 PM
The U.S. Supreme Court decision that Myriad Genetics cannot patent two genes linked to ovarian and breast cancer came as welcome relief to researchers whose work on BRCA1 and BRCA2 genes had been thwarted by legal challenges from the company.
| May 14, 2013
| 4:17 PM
Angelina Jolie’s Op-Ed in the New York Times about getting a double mastectomy after learning that she was at risk of getting breast cancer struck a chord with fellow celebs as well as with Los Angeles Times staffers Anna Gorman and Paul Whitefield,...
| Jun 14, 2013
| 6:01 PM
While the Supreme Court’s decision to forbid patents on human genes knocked out Myriad Genetics' long-guarded patent on two genes linked to breast cancer, the Utah-based company’s stock still rose soon after the news broke. That bit of...
| Jun 13, 2013
| 4:46 PM
When Dr. Wayne Grody heard that the Supreme Court ruled Thursday that Myriad Genetics could not patent two genes linked to breast cancer, the UCLA medical geneticist was minutes from giving a well-worn speech on the years-old case to a room full of...